199 related articles for article (PubMed ID: 21484790)
21. MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies.
Baek G; Tse YF; Hu Z; Cox D; Buboltz N; McCue P; Yeo CJ; White MA; DeBerardinis RJ; Knudsen ES; Witkiewicz AK
Cell Rep; 2014 Dec; 9(6):2233-49. PubMed ID: 25497091
[TBL] [Abstract][Full Text] [Related]
22. Distinct protein and mRNA kinetics of skeletal muscle proton transporters following exercise can influence interpretation of adaptations to training.
McGinley C; Bishop DJ
Exp Physiol; 2016 Dec; 101(12):1565-1580. PubMed ID: 27689626
[TBL] [Abstract][Full Text] [Related]
23. Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.
Todenhöfer T; Seiler R; Stewart C; Moskalev I; Gao J; Ladhar S; Kamjabi A; Al Nakouzi N; Hayashi T; Choi S; Wang Y; Frees S; Daugaard M; Oo HZ; Fisel P; Schwab M; Schaeffeler E; Douglas J; Hennenlotter J; Bedke J; Gibb EA; Fazli L; Stenzl A; Black PC
Mol Cancer Ther; 2018 Dec; 17(12):2746-2755. PubMed ID: 30262589
[TBL] [Abstract][Full Text] [Related]
24. Prolonged hypoxia induces monocarboxylate transporter-4 expression in mesenchymal stem cells resulting in a secretome that is deleterious to cardiovascular repair.
Saraswati S; Guo Y; Atkinson J; Young PP
Stem Cells; 2015 Apr; 33(4):1333-44. PubMed ID: 25537659
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid transport in the choriocarcinoma placenta cell line JEG-3 proceeds independently of the proton-dependent transporters MCT1 and MCT4.
Ishiguro Y; Furugen A; Narumi K; Nishimura A; Hirano T; Kobayashi M; Iseki K
Drug Metab Pharmacokinet; 2018 Dec; 33(6):270-274. PubMed ID: 30341000
[TBL] [Abstract][Full Text] [Related]
27. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.
Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y
Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884
[TBL] [Abstract][Full Text] [Related]
28. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
29. Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.
Gotanda Y; Akagi Y; Kawahara A; Kinugasa T; Yoshida T; Ryu Y; Shiratsuchi I; Kage M; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2941-7. PubMed ID: 23780984
[TBL] [Abstract][Full Text] [Related]
30. High glucose and interleukin 1β-induced apoptosis in human umbilical vein endothelial cells involves in down-regulation of monocarboxylate transporter 4.
Wang D; Wang Q; Yan G; Qiao Y; Sun L; Zhu B; Tang C; Gu Y
Biochem Biophys Res Commun; 2015 Oct; 466(4):607-14. PubMed ID: 26363456
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
[TBL] [Abstract][Full Text] [Related]
32. Monocarboxylate transporter 4 deficiency enhances high-intensity interval training-induced metabolic adaptations in skeletal muscle.
Tamura Y; Jee E; Kouzaki K; Kotani T; Nakazato K
J Physiol; 2024 Apr; 602(7):1313-1340. PubMed ID: 38513062
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide induces the expression of the monocarboxylate transporter MCT4 in cultured astrocytes by a cGMP-independent transcriptional activation.
Marcillac F; Brix B; Repond C; Jöhren O; Pellerin L
Glia; 2011 Dec; 59(12):1987-95. PubMed ID: 21901758
[TBL] [Abstract][Full Text] [Related]
34. Na(+)/H(+) antiporter (NHE1) and lactate/H(+) symporters (MCTs) in pH homeostasis and cancer metabolism.
Counillon L; Bouret Y; Marchiq I; Pouysségur J
Biochim Biophys Acta; 2016 Oct; 1863(10):2465-80. PubMed ID: 26944480
[TBL] [Abstract][Full Text] [Related]
35. MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.
Xu W; Zhang Z; Zou K; Cheng Y; Yang M; Chen H; Wang H; Zhao J; Chen P; He L; Chen X; Geng L; Gong S
Cell Death Dis; 2017 May; 8(5):e2761. PubMed ID: 28471448
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.
Long Y; Gao Z; Hu X; Xiang F; Wu Z; Zhang J; Han X; Yin L; Qin J; Lan L; Yin F; Wang Y
Cancer Med; 2018 Sep; 7(9):4690-4700. PubMed ID: 30051648
[TBL] [Abstract][Full Text] [Related]
37. Effect of mutations affecting Na+: H+ antiport activity on tumorigenic potential of hamster lung fibroblasts.
Lagarde AE; Franchi AJ; Paris S; Pouysségur JM
J Cell Biochem; 1988 Mar; 36(3):249-60. PubMed ID: 2837494
[TBL] [Abstract][Full Text] [Related]
38. The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms.
Andersen AP; Samsøe-Petersen J; Oernbo EK; Boedtkjer E; Moreira JMA; Kveiborg M; Pedersen SF
Int J Cancer; 2018 Jun; 142(12):2529-2542. PubMed ID: 29363134
[TBL] [Abstract][Full Text] [Related]
39. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.
Ullah MS; Davies AJ; Halestrap AP
J Biol Chem; 2006 Apr; 281(14):9030-7. PubMed ID: 16452478
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device.
Shi H; Jiang H; Wang L; Cao Y; Liu P; Xu X; Wang Y; Sun L; Niu H
Cell Cycle; 2015; 14(19):3058-65. PubMed ID: 26125467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
